Robert W Malone MD, was at the Salk Institute in 1987 and 1988. There, he pioneered in-vitro RNA transfection and also in-vivo RNA transfection in frog embryos, as well as mice. Malone’s research was then continued at Vical in 1989, where the first rat experiments were designed by him.
Dr. Malone carried on his research into mRNA vaccination during the 1990s, culminating in a mucosal patent that was issued in 2000. He also helped revolutiionise the field of cationic liposomes for the use in RNA vaccinations, work that was far ahead of its time.
However, Dr Malone does not agree with the roll-out of the current mRNA Covid-19 vaccines by Pfizer and Moderna and has been very outspoken about them over the past couple of months.
Dr Malone was recently interviewed by investigative journalist Sonia Elijah, and you can watch the interview in full below…
Subscribe now to make sure you receive the latest uncensored news in your inbox…
WE URGENTLY NEED YOUR HELP…
We’re not funded by the Government
to publish lies & propaganda on their
behalf like the mainstream media.
Instead, we rely solely on our support. So
please support us in our efforts to bring you
honest, reliable, investigative journalism
today. It’s secure, quick and easy…
Just choose your preferred method
to show your support below support
Categories: Breaking News, Opinion Pages, World News
Scientists lose their religion usually pretty fast .That’s the problem for the world
A very informative discussion. Thank you very much. 👍💕
It appears over time the media/tech/pharma strategy can be adapted to pivot towards Early Care in the community, using safe effective repurposed treatments. The local doctors backed by local lawyers are the on-the-ground folks who can change the strategy to a more effective one. It makes sense, it addresses the issue of vaccine long term safety and it saves lives…
On-the-ground doctors are so afraid because they have no legal backing. They need to be protected by a movement of free legal aid to fight for the freedom to use off-label medicines for the early stages of disease.